Actavia Life Sciences, Inc.
RASP
$0.004
-$0.0285-87.69%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.40K | 19.20K | 75.00K | 2.50K | 2.20K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 47.20K | 7.00K | 20.70K | 34.60K | 50.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 48.60K | 26.20K | 95.70K | 37.10K | 52.30K |
|
|
|||||
| Total Current Assets | 48.60K | 26.20K | 95.70K | 37.10K | 52.30K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 48.60K | 26.20K | 95.70K | 37.10K | 52.30K |
|
|
|||||
| Total Accounts Payable | 1.50M | 1.51M | 959.70K | 1.48M | 1.47M |
| Total Accrued Expenses | 420.90K | 388.60K | 878.90K | 315.40K | 236.90K |
| Short-term Debt | 304.00K | 225.70K | 211.00K | 215.50K | 220.40K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1.90K | 1.60K | 2.00K | -- | -- |
| Total Other Current Liabilities | 1.90K | 1.60K | 2.00K | -- | -- |
| Total Current Liabilities | 2.23M | 2.13M | 2.05M | 2.01M | 1.92M |
|
|
|||||
| Total Current Liabilities | 2.23M | 2.13M | 2.05M | 2.01M | 1.92M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 304.00K | 225.70K | 211.00K | 215.50K | 220.40K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.23M | 2.13M | 2.05M | 2.01M | 1.92M |
|
|
|||||
| Common Stock & APIC | 26.73M | 26.71M | 26.71M | 26.63M | 26.63M |
| Retained Earnings | -28.91M | -28.81M | -28.66M | -28.61M | -28.50M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -2.18M | -2.10M | -1.96M | -1.98M | -1.87M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.18M | -2.10M | -1.96M | -1.98M | -1.87M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.18M | -2.10M | -1.96M | -1.98M | -1.87M |
|
|
|||||
